Annotation of pituitary neuroendocrine tumors with genome-wide expression analysis

[1]  A. Wilkinson,et al.  Transcription factor immunohistochemistry in the diagnosis of pituitary tumours. , 2021, European journal of endocrinology.

[2]  Shaolong Sun,et al.  A novel tp53-associated nomogram to predict the overall survival in patients with pancreatic cancer , 2021, BMC cancer.

[3]  Yoshihiro Yamanishi,et al.  The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer , 2021, Cancer science.

[4]  Ming-Rong Wang,et al.  FKBP10 promotes proliferation of glioma cells via activating AKT-CREB-PCNA axis , 2021, Journal of biomedical science.

[5]  Bingwei Li,et al.  TARBP2 promotes tumor angiogenesis and metastasis by destabilizing antiangiogenic factor mRNAs , 2021, Cancer science.

[6]  C. Lindskog,et al.  TGFBR3L—An Uncharacterised Pituitary Specific Membrane Protein Detected in the Gonadotroph Cells in Non-Neoplastic and Tumour Tissue , 2020, Cancers.

[7]  A. Ferreira-Hermosillo,et al.  Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors , 2020, Scientific Reports.

[8]  Chao Ma,et al.  Prognostic Implications of Novel Ten-Gene Signature in Uveal Melanoma , 2020, Frontiers in Oncology.

[9]  Arvind Y. M. Sundaram,et al.  Distinct Pattern of Endoplasmic Reticulum Protein Processing and Extracellular Matrix Proteins in Functioning and Silent Corticotroph Pituitary Adenomas , 2020, Cancers.

[10]  Limei Liu,et al.  Analysis of the prognostic significance of solute carrier (SLC) family 39 genes in breast cancer , 2020, Bioscience reports.

[11]  Ce Li,et al.  FKBP10 Acts as a New Biomarker for Prognosis and Lymph Node Metastasis of Gastric Cancer by Bioinformatics Analysis and in Vitro Experiments , 2020, OncoTargets and therapy.

[12]  Wenjin Lv,et al.  IKBIP is a novel EMT-related biomarker and predicts poor survival in glioma , 2020, bioRxiv.

[13]  Hongda Lu,et al.  KRT8 and KRT19, associated with EMT, are hypomethylated and overexpressed in lung adenocarcinoma and link to unfavorable prognosis , 2020, Bioscience reports.

[14]  Jincheng Xu,et al.  Elastin is a key factor of tumor development in colorectal cancer , 2020, BMC Cancer.

[15]  P. Baldi,et al.  FKBP10 Regulates Protein Translation to Sustain Lung Cancer Growth. , 2020, Cell reports.

[16]  J. Bollerslev,et al.  Invited Review: Pathology of pituitary neuroendocrine tumours: present status, modern diagnostic approach, controversies and future perspectives from a neuropathological and clinical standpoint , 2020, Neuropathology and applied neurobiology.

[17]  J. Bertherat,et al.  Pangenomic Classification of Pituitary Neuroendocrine Tumors. , 2019, Cancer cell.

[18]  O. Wang,et al.  IGSF1: A novel oncogene regulates the thyroid cancer progression , 2019, Cell biochemistry and function.

[19]  B. Fox,et al.  The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes , 2018, Clinical Cancer Research.

[20]  Publisher's Note , 2018, Anaesthesia.

[21]  B. Engström,et al.  Histopathological classification of non-functioning pituitary neuroendocrine tumors , 2017, Pituitary.

[22]  C. Lindskog,et al.  A specific antibody to detect transcription factor T-Pit: a reliable marker of corticotroph cell differentiation and a tool to improve the classification of pituitary neuroendocrine tumours , 2017, Acta Neuropathologica.

[23]  M. Lopes,et al.  The 2017 World Health Organization classification of tumors of the pituitary gland: a summary , 2017, Acta Neuropathologica.

[24]  Z. Helyes,et al.  Role of hemokinin-1 in health and disease , 2017, Neuropeptides.

[25]  R. Lloyd,et al.  WHO classification of tumours of endocrine organs , 2017 .

[26]  P. Chanson,et al.  From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal. , 2017, Endocrine-related cancer.

[27]  J. Ku,et al.  FAIM2, as a novel diagnostic maker and a potential therapeutic target for small-cell lung cancer and atypical carcinoid , 2016, Scientific Reports.

[28]  L. Melchior,et al.  A high-throughput analysis of the IDH1(R132H) protein expression in pituitary adenomas , 2016, Pituitary.

[29]  Lior Pachter,et al.  Near-optimal probabilistic RNA-seq quantification , 2016, Nature Biotechnology.

[30]  T. Strom,et al.  Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas. , 2016, European journal of endocrinology.

[31]  F. Pontén,et al.  Oncogene-Induced Senescence in Pituitary Adenomas—an Immunohistochemical Study , 2016, Endocrine Pathology.

[32]  S. Asa,et al.  The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas , 2015, Endocrine Pathology.

[33]  C. Spearman.  The proof and measurement of association between two things. , 2015, International journal of epidemiology.

[34]  E. Knosp,et al.  Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. , 2015, Journal of neurosurgery.

[35]  F. Faucz,et al.  Is IGSF1 involved in human pituitary tumor formation? , 2015, Endocrine-related cancer.

[36]  M. Ciriolo,et al.  Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity. , 2015, Cancer letters.

[37]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[38]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[39]  Zhuchu Chen,et al.  Identification of the proteomic variations of invasive relative to non‐invasive non‐functional pituitary adenomas , 2014, Electrophoresis.

[40]  Yunli Zhou,et al.  Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma , 2014, Molecular and Cellular Endocrinology.

[41]  L. Kasuki,et al.  ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas , 2013, PloS one.

[42]  H. Earp,et al.  Molecular Pathways Molecular Pathways : MERTK Signaling in Cancer , 2013 .

[43]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[44]  Fionn Murtagh,et al.  Ward’s Hierarchical Agglomerative Clustering Method: Which Algorithms Implement Ward’s Criterion? , 2011, Journal of Classification.

[45]  G. Stalla,et al.  ZAC1 target genes and pituitary tumorigenesis , 2010, Molecular and Cellular Endocrinology.

[46]  M. Robinson,et al.  A scaling normalization method for differential expression analysis of RNA-seq data , 2010, Genome Biology.

[47]  J. Sznajder,et al.  Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[48]  K. Dudley,et al.  Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma. , 2009, Endocrine-related cancer.

[49]  J. Hald,et al.  The clinical response to somatostatin analogues in acromegaly correlates to the somatostatin receptor subtype 2a protein expression of the adenoma , 2008, Clinical endocrinology.

[50]  Joachim Selbig,et al.  pcaMethods - a bioconductor package providing PCA methods for incomplete data , 2007, Bioinform..

[51]  J. Drouin,et al.  Tpit determines alternate fates during pituitary cell differentiation. , 2003, Genes & development.

[52]  J. Drouin,et al.  A Pituitary Cell-Restricted T Box Factor, Tpit, Activates POMC Transcription in Cooperation with Pitx Homeoproteins , 2001, Cell.

[53]  S. Camper,et al.  Steroidogenic factor 1 (SF1) is essential for pituitary gonadotrope function. , 2001, Development.

[54]  S. Asa,et al.  The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph. , 1996, The Journal of clinical endocrinology and metabolism.

[55]  S. Asa,et al.  Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas. , 1993, The Journal of clinical endocrinology and metabolism.

[56]  Larry W. Swanson,et al.  Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1 , 1990, Nature.

[57]  H. Bourne,et al.  GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours , 1989, Nature.

[58]  Subham Ghosh.  Adenomas , 2021, Handbook of Imaging in Pulmonary Disease.

[59]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[60]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[61]  E. Tartour,et al.  [Neuroendocrine tumors]. , 1992, La Revue du praticien.